1. Home
  2. CLNN vs SGRP Comparison

CLNN vs SGRP Comparison

Compare CLNN & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • SGRP
  • Stock Information
  • Founded
  • CLNN 2012
  • SGRP 1967
  • Country
  • CLNN United States
  • SGRP United States
  • Employees
  • CLNN N/A
  • SGRP N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • SGRP Business Services
  • Sector
  • CLNN Health Care
  • SGRP Consumer Discretionary
  • Exchange
  • CLNN Nasdaq
  • SGRP Nasdaq
  • Market Cap
  • CLNN 23.1M
  • SGRP 28.2M
  • IPO Year
  • CLNN N/A
  • SGRP 1996
  • Fundamental
  • Price
  • CLNN $5.95
  • SGRP $1.19
  • Analyst Decision
  • CLNN Strong Buy
  • SGRP
  • Analyst Count
  • CLNN 5
  • SGRP 0
  • Target Price
  • CLNN $33.00
  • SGRP N/A
  • AVG Volume (30 Days)
  • CLNN 101.0K
  • SGRP 294.9K
  • Earning Date
  • CLNN 08-14-2025
  • SGRP 08-14-2025
  • Dividend Yield
  • CLNN N/A
  • SGRP N/A
  • EPS Growth
  • CLNN N/A
  • SGRP N/A
  • EPS
  • CLNN N/A
  • SGRP N/A
  • Revenue
  • CLNN $286,000.00
  • SGRP $143,501,000.00
  • Revenue This Year
  • CLNN N/A
  • SGRP $7.22
  • Revenue Next Year
  • CLNN $2,178.18
  • SGRP N/A
  • P/E Ratio
  • CLNN N/A
  • SGRP N/A
  • Revenue Growth
  • CLNN N/A
  • SGRP N/A
  • 52 Week Low
  • CLNN $2.28
  • SGRP $0.91
  • 52 Week High
  • CLNN $6.90
  • SGRP $2.48
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 65.46
  • SGRP 54.71
  • Support Level
  • CLNN $5.12
  • SGRP $1.14
  • Resistance Level
  • CLNN $6.49
  • SGRP $1.41
  • Average True Range (ATR)
  • CLNN 0.63
  • SGRP 0.07
  • MACD
  • CLNN 0.10
  • SGRP -0.00
  • Stochastic Oscillator
  • CLNN 81.76
  • SGRP 31.25

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

Share on Social Networks: